Neil Kumar

Co-Founder at Bridgebio Pharma LLC

Neil Kumar

Neil Kumar

Co-Founder at Bridgebio Pharma LLC

Overview
Career Highlights

Eidos Therapeutics, Inc.
Bridgebio Pharma LLC

RelSci Relationships

2179

Number of Boards

3

Contact Data
Trying to get in touch with Neil Kumar? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Neil Kumar likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Operating Officer at BridgeBio Pharma, Inc.

Relationship likelihood: Strong

Co-Founder at PellePharm, Inc.

Relationship likelihood: Strong

Co-Founder & Director at PellePharm, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at BridgeBio Pharma, Inc.

Relationship likelihood: Strong

Founder at Biotechnology Innovation Organization

Relationship likelihood: Strong

Director at University of California - Berkeley

Relationship likelihood: Strong

Partner at Aisling Capital

Relationship likelihood: Strong

Director & Vice Chairman-Food Governing Body at Biotechnology Innovation Organization

Relationship likelihood: Strong

Co-Chair at Biotechnology Innovation Organization

Relationship likelihood: Strong

President & Chief Medical Officer at Eidos Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Neil Kumar
Potential Connections via
Relationship Science
You
Neil Kumar
Co-Founder at Bridgebio Pharma LLC
Education
Ph.D Chemical Engineering

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

MS in Chemical Engineering

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Career History
Co-Founder
Current

BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA.

Chief Executive Officer & Director
Current

Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA.

Interim Head, Business Development & Operations
2012 - 2014

MyoKardia, Inc. operates as a biopharmaceutical company. It engages in the discovery, development, and commercialization of targeted therapies for the treatment of cardiovascular diseases. The firm focuses on the treatment of heritable cardiomyopathies, genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. It offers MYK-46, an orally-administered small molecule designed to reduce excessive cardiac muscle contractility to hypertrophic cardiomyopathy. The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in San Francisco, CA.

Transactions
Details Hidden

Eidos Therapeutics, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Neil Kumar. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Neil Kumar's profile does not indicate a business or promotional relationship of any kind between RelSci and Neil Kumar.